REQUEST A DEMO
Total
USD $0.00
Search more companies

PT Rohto Laboratories Indonesia (Indonesia)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: PT Rohto Laboratories Indonesia Profile Updated: November 25, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English Download a sample report

pt. rohto laboratories indonesia is a pharmaceutical and cosmetic company. The company develops and distributes a range of products, including eye drops such as Rohto Dry Fresh, Rohto Cool, and Rohto Eye Flush. Their products are available in minimarkets, supermarkets, pharmacies, and online stores.

Headquarters
Kota Jakarta Barat Slipi Palmerah Dki Jakarta
West Jakarta; Jakarta; Postal Code: 11410

Contact Details: Purchase the PT Rohto Laboratories Indonesia report to view the information.

Website: http://www.rohto.co.id

Basic Information
Total Employees:
Purchase the PT Rohto Laboratories Indonesia report to view the information.
Registered Capital:
Purchase the PT Rohto Laboratories Indonesia report to view the information.
Financial Auditors:
Purchase the PT Rohto Laboratories Indonesia report to view the information.
Incorporation Date:
February 05, 1996
Key Executives
Purchase this report to view the information.
President Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
Purchase this report to view the information.
Company Performance
Financial values in the chart are available after PT Rohto Laboratories Indonesia report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency IDR. Absolute financial data is included in the purchased report.
Net sales revenue
13.67%
Total operating revenue
13.67%
Total Assets
12.59%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?